CU6 6.90% $5.42 clarity pharmaceuticals ltd

Research/Valuation, page-176

  1. 1,934 Posts.
    lightbulb Created with Sketch. 319
    The possibility has been discussed, but I've only found two studies that have determined CKD risk.

    https://academic.oup.com/ckj/article/13/6/1049/5549858

    https://www.sciencedirect.com/science/article/abs/pii/S0302283822024010

    the second article has indicated that the cumulative dosage e was >50GBq for the 3 cases with renal damage.

    are there article of studies you can direct me to further to determine this?

    177lu dotate seems to have more risk?

    https://jnm.snmjournals.org/content/63/10/1503
 
watchlist Created with Sketch. Add CU6 (ASX) to my watchlist
(20min delay)
Last
$5.42
Change
0.350(6.90%)
Mkt cap ! $1.689B
Open High Low Value Volume
$5.10 $5.53 $5.10 $8.270M 1.560M

Buyers (Bids)

No. Vol. Price($)
2 1951 $5.40
 

Sellers (Offers)

Price($) Vol. No.
$5.44 4280 2
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
CU6 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.